| Novartis Pharmaceuticals Corporation | 32 | $136,219 | $112,965 – $142,771 |
| Regeneron Pharmaceuticals, Inc. | 12 | $149,768 | $144,800 – $151,136 |
| Vertex Pharmaceuticals Incorporated | 9 | $144,925 | $144,925 – $152,000 |
| Incyte Corporation | 6 | $125,000 | $121,250 – $125,000 |
| Biogen Inc. | 6 | $113,600 | $113,600 – $119,900 |
| Parexel International LLC | 3 | $168,712 | $165,356 – $173,260 |
| IQVIA RDS Inc. | 3 | $170,000 | $162,500 – $171,000 |
| Edwards Lifesciences LLC | 3 | $118,664 | $117,031 – $118,664 |
| ClinChoice Inc. | 3 | $153,090 | $149,870 – $158,336 |
| Cytel Inc. | 3 | $142,726 | $139,096 – $153,863 |
| CSL Behring L.L.C. | 2 | $158,000 | $158,000 – $158,000 |
| Sandoz Inc. | 2 | $169,754 | $168,352 – $171,156 |
| Syneos Health, LLC | 2 | $111,873 | $99,263 – $124,483 |
| H2O Clinical, LLC | 1 | $175,000 | $175,000 – $175,000 |
| Foundation Medicine, Inc. | 1 | $123,760 | $123,760 – $123,760 |
| Adaptimmune LLC | 1 | $175,000 | $175,000 – $175,000 |
| Apellis Pharmaceuticals Inc. | 1 | $154,400 | $154,400 – $154,400 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | 1 | $165,000 | $165,000 – $165,000 |
| Fortrea Inc. | 1 | $126,110 | $126,110 – $126,110 |
| Novartis Institutes for BioMedical Research, Inc. | 1 | $106,600 | $106,600 – $106,600 |
| Neurocrine Biosciences, Inc. | 1 | $141,856 | $141,856 – $141,856 |
| Nektar Therapeutics | 1 | $154,669 | $154,669 – $154,669 |
| Johns Hopkins University | 1 | $105,000 | $105,000 – $105,000 |
| Janssen Research & Development, LLC | 1 | $145,000 | $145,000 – $145,000 |
| Ora, Inc. | 1 | $182,490 | $182,490 – $182,490 |
| Servier Bio-Innovation LLC | 1 | $172,500 | $172,500 – $172,500 |
| Uswm CT, LLC | 1 | $177,679 | $177,679 – $177,679 |